Reports for SANOFI-AVENTIS CANADA INC
Company Name
SANOFI-AVENTIS CANADA INC
Totals |
||
Shortage reports |
271 |
|
| Actual shortage: | 7 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 14 (5%) | |
| Resolved: | 250 (92%) | |
Discontinuation Reports |
49 |
|
| To be discontinued: | 5 (10%) | |
| Discontinued: | 44 (90%) | |
| Reversed: | 0 (0%) | |
Late reports |
20 (6%) |
|
Overdue reports |
4 (33%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SOFRACORT | 0.5MG 0.05MG 5MG | DROPS | Resolved | 2017-03-16 | 2019-01-10 | 3060 |
| SOFRACORT | 5MG 0.5MG 0.05MG | DROPS | Resolved | 2020-04-07 | 2020-09-08 | 111384 |
| SOFRACORT | 0.05MG 0.5MG 5MG | DROPS | Resolved | 2022-04-29 | 2022-08-16 | 159765 |
| SOFRACORT | 0.05MG 0.5MG 5MG | DROPS | Actual shortage | 2023-08-25 | 2023-12-01 | 202983 |
| SECTRAL | 100MG | TABLET | Resolved | 2018-05-08 | 2018-07-31 | 48844 |
| SECTRAL | 200MG | TABLET | Resolved | 2018-04-18 | 2018-07-27 | 46276 |
| RILUTEK | 50MG | TABLET | Resolved | 2019-11-14 | 2021-09-29 | 98763 |
| RIFADIN | 150MG | CAPSULE | Resolved | 2018-01-10 | 2018-02-02 | 35644 |
| RIFADIN | 150MG | CAPSULE | Resolved | 2019-03-22 | 2021-02-16 | 79293 |
| RIFADIN | 300MG | CAPSULE | Resolved | 2019-03-22 | 2021-02-16 | 79314 |
| RESONIUM CALCIUM | 999MG | POWDER FOR SOLUTION | Resolved | 2019-05-28 | 2019-10-15 | 84937 |
| RESONIUM CALCIUM | 999MG | POWDER FOR SOLUTION | Resolved | 2021-02-16 | 2021-05-22 | 134202 |
| RESONIUM CALCIUM | 999MG | POWDER FOR SOLUTION | Resolved | 2023-10-30 | 2024-02-23 | 208624 |
| RENVELA | 800MG | TABLET | Resolved | 2019-01-04 | 2019-01-10 | 71284 |
| RENVELA | 800MG | TABLET | Actual shortage | 2024-02-16 | 2024-04-10 | 219863 |
| PRIMAQUINE | 26.3MG | TABLET | Resolved | 2018-09-26 | 2019-08-12 | 62424 |
| PRIMAQUINE | 26.3MG | TABLET | Resolved | 2022-03-16 | 2022-07-12 | 156783 |
| PRIMAQUINE | 26.3MG | TABLET | Resolved | 2023-07-19 | 2023-07-21 | 199221 |
| PRALUENT | 75MG | SOLUTION | Avoided shortage | 2018-10-17 | 2018-10-18 | 64484 |
| PRALUENT | 75MG | SOLUTION | Resolved | 2019-04-02 | 2019-04-18 | 80305 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NOVAHISTEX DH | 20MG 5MG | SYRUP | Discontinued | 2019-11-11 | 2020-08-04 | 98374 |
| MYOCHRYSINE | 10MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86067 |
| MYOCHRYSINE | 25MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86070 |
| MYOCHRYSINE | 50MG | SOLUTION | Discontinued | 2019-06-10 | 2019-06-10 | 86073 |
| LIBTAYO | 250MG | SOLUTION | Discontinued | 2023-12-06 | 2023-12-09 | 212566 |
| KEVZARA | 150MG | SOLUTION | Discontinued | 2022-07-12 | 2022-08-02 | 164491 |
| JEVTANA | 40MG | SOLUTION | Discontinued | 2023-06-21 | 2023-09-13 | 196086 |
| IMOVANE | 5.0MG | TABLET | To be discontinued | 2022-05-16 | 2022-05-16 | 160688 |
| FLAGYL | 500MG | CAPSULE | Discontinued | 2023-03-22 | 2023-03-22 | 187634 |
| FLAGYL | 10% | CREAM | To be discontinued | 2024-03-28 | 2024-03-28 | 223877 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57608 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57613 |
| ELOXATIN | 5MG | SOLUTION | Discontinued | 2018-08-07 | 2018-10-24 | 57616 |
| DIABETA | 2.5MG | TABLET | Discontinued | 2019-12-11 | 2020-08-04 | 100935 |
| DIABETA | 5MG | TABLET | Discontinued | 2019-12-11 | 2020-08-04 | 100938 |
| DEMEROL | 50MG | TABLET | Discontinued | 2019-11-11 | 2020-07-29 | 98380 |
| CONDYLINE | 0.5% | SOLUTION | To be discontinued | 2021-07-13 | 2021-07-13 | 142368 |
| CLOMID | 50MG | TABLET | Discontinued | 2017-03-22 | 2017-03-22 | 3917 |
| CLAFORAN - PWS INJ 2.0G/VIAL | 2G | POWDER FOR SOLUTION | Discontinued | 2017-03-20 | 2017-04-05 | 3685 |
| CLAFORAN - PWS INJ 1.0G/VIAL | 1G | POWDER FOR SOLUTION | Discontinued | 2017-03-16 | 2017-05-02 | 3103 |